Sexual Function
PT-141
Desire From the Source
The only peptide that targets sexual desire at its neurological origin. Reconstitution, on-demand dosing, mechanism of action, stacking protocols, and complete safety profile.
Peptide
Bremelanotide (PT-141)
FDA Status
Approved as Vyleesi® (2019)
Dose
0.5–2.0 mg · On-demand
Onset
30–60 minutes · Window up to 24 hours
Who this guide is for.
Men and women experiencing low desire that hasn't responded to traditional treatments. Works through the brain, not blood flow.
What's Inside
28 pages. 10 chapters.
Not a blog post. A protocol.
Evidence-Based
Every dosing recommendation is grounded in clinical research and practitioner protocols — not forum anecdotes.
Action-Ready
Not theory — a step-by-step operating manual from first reconstitution to cycle end.
Safety-First
Full side effect profiles, contraindications, and monitoring requirements. No information withheld.
Get the PT-141 guide.
28 pages. 10 chapters. Everything from reconstitution to cycle end — in one PDF.